why choose us

Clinical Trials Search

Showing 8,750 of 132,656 result(s)
Evaluation of the Efficacy of Two Dietary Supplements on Hair Loss and Hair Aspect

Status: Completed

Condition: Healthy Volunteers

Interventions: The study foresees the intake of 2 capsules per day during 84 days

Date: 2023-08-31

Placenta Perfusion and Sufficiency Study

Status: Completed

Condition: Placenta Diseases, Diagnosis

Interventions: Ultra sound of the uterus and uterine blood vessels

Date: 2023-08-31

Long Term Effects of Action Observation Therapy and Mirror Therapy on Upper Limb Functions

Status: Completed

Condition: Stroke

Interventions: The patients in the AOT group will be required to observe the upper limb movements or functional actions in video clips and to execute what they had o

Date: 2023-08-31

Validation of the Clinical and Antimicrobial Effectiveness of a Clorexidine and Sodium DNA Based Mouthwash in Patients With Stage III and IV Periodontitis

Status: Completed

Condition: Periodontitis

Interventions: Subgingival biofilm ultrasonic debridement

Date: 2023-08-31

Additional Recombinant COVID-19 Humoral and Cell-Mediated Immunogenicity in Immunosuppressed Populations

Status: Completed

Condition: Immunosuppression

Interventions: Novavax COVID-19 Vaccine Booster for Omicron XBB.1.5

Date: 2023-08-31

Pharmacogenomics Effects on High-Dose Methotrexate Clearance in Patients With Diffuse Large B-Cell Lymphoma

Status: Completed

Condition: Central Nervous System Lymphoma

Interventions: Non-interventional study

Date: 2023-08-31

Vibrotactile Coordinated Reset in Parkinson's Disease - Proof of Concept Study

Status: NOT_YET_RECRUITING

Condition: Parkinson Disease

Interventions: The non-invasive neuromodulation hardware system comprises two wireless controllers;battery packs which are fastened to the top of each hand via

Date: 2023-08-31

The Purpose of This Study is to Evaluate the Efficacy and Safety of Aficamten (CK-3773274) Compared to Placebo in Adults With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy

Status: Completed

Condition: Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy

Interventions: Oral Tablet

Date: 2023-08-31

A Study of Sacituzumab Govitecan (IMMU-132) in Platinum-resistant Ovarian Cancer Patients

Status: Completed

Condition: Ovarian Carcinoma

Interventions: Sacituzumab govitecan will be administered at 10 mg;kg weekly as an infusion for 2 consecutive weeks (2 weekly doses plus 1 week without treatmen

Date: 2023-08-31

Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation

Status: Completed

Condition: Allogeneic Hematopoietic Stem Cell Transplantation

Interventions: Given Day-5, Day-4, Day-3, Day-2

Date: 2023-08-31